An enclosed efferent, afferent reservoir breathing system (Maxima, Life Air Pty Ud), being valveless, was compared to a simple afferent reservoir system (Humphrey ADE, A mode), having a valve, by assessing fresh gas flow (VF) requirements, with respect to ventilation (VE), that prevents rebreathing in volunteers, awake and breathing spontaneously. The results are recorded in terms of the quotient VFIVE associated with the onset of rebreathing. At the same time four clinical methods for assessing rebreathing were evaluated from the perspective of suitability for practical application during anaesthesia.
The Maxima is a new breathing system of the displacement afferent reservoir type!. The functional characteristics of this valveless, non-absorber system are that of a single universal system (not a combination of systems) with maximal efficiency in all modes of ventilation. For this to be the case it must have the characteristic of selectively eliminating alveolar gas in both controlled 2 and spontaneous ventilation. For the selective elimination of alveolar gas during spontaneous ventilation, the breathing system must have a similar performance characteristic to presently used, valve-operated, afferent reservoir breathing systems. As the Humphrey ADE is a commonly used breathing system of this type (Mapleson A), and functionally identical to a Lack breathing system3.4, we compared its fresh gas flow (VF) requirements during spontaneous breathing with that of the Maxima breathing system. The objective was to determine the minimum YF required to prevent rebreathing.
Rebreathing is the term used to describe the reinhalation of alveolar gas into the alveolar regions of the lung, greater than the obligatory amount that is inhaled from the anatomical deadspace following the expiratory phase. Provided no rebreathing occurs, alveolar ventilation (YA) is normally equal to effective ventilation (YAe). However, if rebreathing occurs, that portion of ventilation which involves rebreathed alveolar gas, termed rebreathing ventilation (YR), encroaches upon YA such that YAe= VA-YR.
Rebreathing occurs in sodalime-free systems when the patient demand for effective alveolar ventilation is not met by the interaction of breathing system dynamics and YF. A reliable qualitative method which detects this failure of demand is needed. Methods used to detect rebreathing include:
(i) monitoring the rise in end-tidal carbon dioxide concentrations (PEC0 2 )5, (ii) measuring the increase in total ventilation response to rebreathing 6 (iv) measuring the minimum inspired carbon dioxide concentration (PIminC02Y4 and (v) capnographic sampling in the exhaust limb, near the elimination point of afferent reservoir systems ( Figure 1 ) to measure the minimum CO 2 eliminated (ElimC0 2 )8.9. The elimination point of afferent reservoir systems is the outlet of the patient connector ( Figure 1 ), whether or not a proximal or distal valve is used, as in the case of the Magill and ADE systems respectively.
The F-piece for directing gas flow during the expiratory phase (arrow illustrating preferential direction of flow), with (A) the combined pneumotach and capnography sampling site for monitoring minute ventilation (,VE), end-tidal C02 (PE C02) and minimum inspired C02 (PIminC02), and (B) the efferent limb C02 sampling site for measuring minimum eliminated C02 (ElimCo2) with sampling tube interposed between 15 mm corrugated plastic tube and F-piece efferent outlet (Ef), and (Af) the afferent tube attachment port.
Methods (i), (ii) and (iii) are quantitative methods for detecting rebreathing, which rely upon there being a significant change in the measurement, the absolute value of which is influenced by central nervous system depressant drugs. To avoid the influence of these drugs, a study using volunteers, awake and breathing air was chosen. All five of these methods were used to determine the YF at which rebreathing begins, thereby providing a means for comparing these monitoring methods and assessing their suitability for use in the clinical situation.
METHODS
Permission to do the study was granted by the Hospital Ethics Committee. It was performed at sea level on eight volunteer anaesthetists while they rested on a bed in the laboratory. By random choice, four subjects ventilated through the Humphrey A system first and the Maxima system second, and four in the Anaesthesia and Intensive Care. Vol. 23, No. 3, June, 1995 reverse order. They were attached to the two breathing systems by a mouthpiece, and wore a nose-clip. Piped air supplied through a rotameter calibrated with an RT200 Timeter calibration analyser was used as fresh gas. The Datex Ultima combined pneumotachograph and capnograph was used to measure minute volume (minute ventilation), minimum inspired and end-tidal carbon dioxide levels with sampling between the mouthpiece and the breathing system. The instrument was calibrated using a water displacement spirometer. The mean of ten consecutive readings of ventilation was taken. Concentrations of carbon dioxide eliminated in the efferent limb of the patient connector were measured continuously using a Datex Cardiocap I monitor. Sampling rates were 150 ml.min -I. The Datex Safe + Sure calibration mixture, comprising 50/0 CO 2 , 55% O 2 and 40% N 2 0 was used to calibrate both capnographs.
The YF was initially set at a value considerably higher than that of the ventilation of the subjects (10 l.min-I). After a period of acclimatization until a steady state had been maintained for at least three minutes, readings were taken. The YF was then reduced in steps every five minutes by 1I.min-1 , and then by 0.5 I.min-1 as the YF fell below 8I.min-1 • Baseline levels of ventilation (B. YE) were taken as the mean of all values obtained when the YF exceeded the minute ventilation. The lowest ElimPC0 2 and PlminC0 2 and highest PEC0 2 levels were recorded for each flow rate.
As baseline levels of ventilation change from subject to subject, and in addition differ between the anaesthetized and the awake, it is more meaningful to express in terms of ventilation the minimum YF requirement to prevent rebreathing. Therefore, all results are expressed in terms of the quotient YF/VE.
The criterion for the onset of rebreathing was taken as the YF at which:
(i) PE CO 2 level increased from the baseline value by 0.2%, similar to the 0.25% used in an earlier studyS, provided there was no associated decrease in ventilation, (ii) an increase of 10% in minute ventilation (R.YE) from the baseline value (B.YE) occurred 6 • 7
, with or without an increase in end-tidal CO 2 , and provided there was no associated decrease in PEC02· (iii) PIminC0 2 level increased by 0.2% above zer0 4 , and (iv) Minimum ElimC0 2 level by 0.5% CO 2 above zero. A comparison of the flow requirements for the two breathing systems, using the methods which proved to be consistent and reliable, could then be made. Table 1 summarizes the VFIVE quotients at which the onset of rebreathing was detected using four different methods, applied to the ADE and Maxima breathing systems with respective ranges of values for VFIVE of 0.89-0.72 and 0.86-0.69. The average VF values obtained for the onset of rebreathing using the three reputable methods (i, ii, and iv) in the Humphrey ADE and Maxima systems were 73.5 standard error (±) 8 ml.kg-'.min-' and 74.8 (±) 8 ml.kg I.min I respectively. The average VFIVE values for the onset of rebreathing using methods i, ii, and iv in the Humphrey ADE and Maxima systems were 0.80±0.1O and 0.77±0.09.
RESULTS

On Comparing Methods for Detecting Rebreathing
The relationship between the PEC0 2 and R.VE methods coincided better with those subjects that felt more comfortable under the conditions of the experiment. Contrast for example subject 1, with diving experience, and subject 8 without (see Figures 2a and  2b ). It is a safer method that detects rebreathing or impending rebreathing at a higher flow rate than other methods. The ElimC0 2 method demonstrates this characteristic in detecting rebreathing or impending rebreathing at flow rates which were usually greater than (five subjects out of eight) or equal to (three subjects out of eight) the highest flows at which the same was detected using the other methods.
Although in this study the results using the PIminC0 2 method, with somewhat strict criteria, gave an acceptable mean value for VFIVE at which the onset of rebreathing occurred, the range of values varied from the highest flow rates ( Table 1 , and reflect the range of results obtained when all four methods were employed. From these results, the values obtained for each subject were then recorded in Table l . The least stable result was subject 8 (Figure 2b) , and it is instructive in that, when the minute volume increased by 10070 at a higher flow using the Humphrey A system than the Maxima system, the ElimC0 2 method reflected accurately this inconstant event.
The Wilcoxon "matched pairs signed rank sum test" was applied. No significant difference between the Maxima and the ADE breathing systems was found in the baseline VE (B.VE) and the three reputable methods (the specified increases in Elim.PC0 2 , PEC0 2 and R.VE) for detecting rebreathing. However, when applying the PlminC0 2 method to the two systems, the difference was significant with the null hypothesis being rejected at the 1070 level (P value =0.01). The range Flow rate in L/min
~s~. 6 ... Table I . NB. In Figure 2b , the rise in YE and ElimC02 with the ADE system at 6 I.min -I is within the stated criteria, hence the arrow position at 5.5 I.min -I. NB. Also, the drop in C02 at 6 I.min -I, which would have invalidated the rise in ventilation if it had exceeded the stated criteria for R. VE.
of values found using this method applied to the ADE system was 0.61-0.95, a greater range than with the Maxima system range which was 0.74-0.92. It is an important observation that the PIminC0 2 method in the case of the Maxima system gave the same flow rates as with the EIim.PC0 2 method in all but one case, in which the respective values for VF/VE were 0.8 and 0.89. Between these two methods in the case of the Maxima system, there is no significant difference. However, in the case of the ADE system, the null hypothesis is rejected below the 10/0 level (P<O.OI).
DISCUSSION
Firstly, the results show that there is no important or significant difference in the requirement for fresh gas flows between the valveless Maxima and the Humphrey ADE (A mode) system when used in spontaneous ventilation. As there was also no significant difference between the baseline levels of ventilation (RVE), using the two systems, there is no reason to doubt the validity of the comparison.
Secondly, of the four methods for detecting or anticipating the onset of rebreathing, the highest VF consistently recorded was obtained using the eliminated CO 2 (ElimC0 2 ) method. It is noteworthy that this statement applies to both systems, if one excludes the PIminC0 2 method in the case of the Maxima system, because it would appear to be measuring the same parameter as that of the ElimC0 2 method. Why this should be the case is explained later.
Strictly speaking, the ElimC0 2 method cannot of necessity be an indicator of established rebreathing: however, it is a logical predictor for the onset of rebreathing, which is precisely what we wish to know. This is because a system which selectively eliminates alveolar gas, as afferent reservoir breathing systems should, will display zero carbon dioxide, i.e. fresh gas, in the exhaust limb only when no rebreathing is occurring. This explains why the indicators of rebreathing occurred at values of VF with the ElimC0 2 method, which were either equal or greater than the other methods. Its accurate reflection of rebreathing in the two least stable subject measurements, 6 and 8 in Table 1 or 8 again in Figure 2b , is indicative of the reliability of the method. As a reliable indicator of impending rebreathing and without influence of patient variables, it constitutes a safer monitoring method than any of the others. In addition, the application of the capnograph sampling tube in the proximal efferent! exhaust limb does not add to deadspace in the system, an important factor in paediatric patients, and a technique which may be applied with ease when a facemask is to be used.
There have been many methods described for the clinical assessment of appropriate flow requirements to prevent the onset of rebreathing during anaesthesia 3 -12 • However, as pointed out in the introduction, most of the methods described suffer from major problems in accuracy for routine usage in spontaneous ventilation. During anaesthesia, quantitative methods (i and ii) are not satisfactory for reasons given later and because a) they only indicate rebreathing when physiological changes are evident which result from rebreathing and b) the responsiveness of these changes is influenced by central nervous system depressant drugs. The use of awake volunteers, with a higher metabolic rate than is encountered during anaesthesia, for the evaluation of rebreathing, while making the quantitative methods more reliable and useful in evaluating the breathing system performance, suffers from the minor disadvantage that one cannot say what the flow requirements during anaesthesia should be. But the flow requirements during anaesthesia have already been well defined for afferent reservoir systemsJ-6.12.IJ and are not the objective of this study. The advantage of the responsiveness of ventilation to rebreathing not impeded by central nervous system depressant drugs is important for a reliable definition of rebreathing and has been shown to be one of the most sensitive indicators of rebreathing'. The same is reflected in this study. At no stage did end-tidal CO 2 increase without the level of ventilation having increased first. Increases in minute ventilation as an indication of rebreathing taking place is only a reliable indicator during light planes of anaesthesia and if the influence upon respiration of surgical stimulation is eliminated. The usefulness of this method, therefore, is severely limited.
Though reliable as an indicator of rebreathing, a rise in end-tidal CO 2 can only follow once rebreathing has been established. Given the large storage capacity of the body for CO 2 , a small change in end expired CO 2 reflects a large change in the total CO 2 content, which may be caused by respiratory-depressant drugs or rebreathing. The method cannot distinguish between these two causes.
The PIminC0 2 method 2 · J has the advantage of a qualitative method for detecting rebreathing, but it cannot be defended on theoretical grounds, and it has been strongly suggested that it is a rather late indicator of the evidence of rebreathing 'o . With this method, considerable amounts of rebreathing may occur before the minimum inspired carbon dioxide level begins to exceed zero, because in afferent reservoir breathing systems, extension of the anatomical deadspace into the breathing system (i.e. increased functional deadspace or increased rebreathing) takes place proximally in the afferent tube. Even after establishment of rebreathing, therefore, it is quite likely that the last portion of gas entering the lungs may be CO 2 free.
The most appropriate method suggested for afferent reservoir breathing systems 8 • 9
.", confirmed in this study, is simply to observe the capnograph trace with samples taken in the exhaust or efferent limb and close to the elimination point; yet the method is not in common usage'O.12.1l. The method of measuring PIminC0 2 for indicating rebreathing is shown here to be unreliable when using the ADE system, providing as it did an inconsistent result when compared with the other three methods. In half of the subjects, it was a late sign of rebreathing demonstrating the lowest values for VF/VE compared to other methods in subjects 2, 3, 4, and 6. The findings of other workers evaluating this method using an experimental lung model 'o are thus confirmed.
In contrast to these findings, when the valveless Maxima system was used, the method resulted in the same values for the onset of rebreathing as did the apparently more reliable ElimC0 2 method in 7 out of 8 cases and in subject 4 the difference was minimal. The suggested explanation is that the valveless nature of the Maxima system allows for "eliminated" alveolar gases to be aspirated from the efferent/exhaust limb during the inspiratory phase, when the onset of rebreathing is pending. There is no qualitative difference, therefore, between the PIminC0 2 and the eliminated CO 2 method, when a valveless afferent reservoir breathing system is used. This obviates the need for changing sampling positions between spontaneous and controlled ventilation.
It may be stated in conclusion that, if on statistical grounds there appears to be no significant difference in flow requirements between the Maxima and ADE breathing systems for use in spontaneous ventilation, the possible differences for clinical purposes will be even less important. The advantage of being able to eliminate valves and therefore moving parts in a breathing system is clearly beneficial from the point of view of mechanical reliability. Another advantage, resulting from the valveless characteristic of the Maxima system, is that the normally unreliable minimum inspired CO 2 sampling method becomes as reliable as the most reliable minimum eliminated CO 2 sampling method for reasons already given. However, the most important advantage of the Maxima system, which is a single maximal efficiency system, over combination systems such as the ADE, is the safety Anaesthesia and Intensive Care, Vol. 23, No. 3, June, 1995 feature of having eliminated the need for employing different circuit modes for spontaneous and controlled ventilation.
